• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. ARTISYN; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. ARTISYN; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Catalog Number ARTY
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Erosion (1750); Pain (1994); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.If the device or further details are received at the later date a supplemental medwatch will be sent.(b)(4) total number of events ¿ (b)(4).Artisyn y-shaped mesh ¿ (b)(4).Gynecare gynemesh ps - (b)(4).
 
Event Description
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2014 and the mesh was implanted.Following the procedure, the patient experienced pain and erosion of internal bodily tissue.It was also reported that the patient underwent revisionary procedures.No additional information was provided.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2017 through (b)(6) 2017 supplemental 01 *includes 20 initial files omitted from (b)(6) 2017 submission: artisyn y-shaped mesh ¿ 0 gynecare gynemesh - 10 gynecare gynemesh ps ¿ 10 - attachment: [(b)(6) 2017 oto supplemental 01.Xlsx].
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2017 through (b)(6) 2017 supplemental 02 - attachment: [(b)(6) 2017 oto supplemental 02.Xlsx].
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: (b)(4) 2018.Ethicon mdr summary reporting exemption e2013037 reporting period (b)(4) 2017 through (b)(4) 2017.
 
Manufacturer Narrative
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 2/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 4/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 06/25/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 08/23/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 10/28/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to the fda: 12/19/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 02/18/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 08/24/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 10/22/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to the fda: 02/19/2021.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Manufacturer Narrative
Date sent to fda: 04/19/2021.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2017 through september 30, 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTISYN
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville 08876 0151
Manufacturer (Section G)
ETHICON INC.-GMBH
robert-koch strasse 1
norderstedt
GM  
Manufacturer Contact
elba bello
p.o. box 151, route 22 west
somerville 08876-0151
9082183429
MDR Report Key6981569
MDR Text Key90385038
Report Number2210968-2017-70665
Device Sequence Number1
Product Code OTO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K113205
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 08/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2015
Device Catalogue NumberARTY
Device Lot NumberGK8CJHA0
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/19/2021
Date Device Manufactured09/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
-
-